how many people are on glp-1 drugs in the us Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss GLP-1s Are Most Popular in

2023;110 doi: 10.1016/j.nut.2023.111982

This mini-review discusses clinical studies evaluating adjuvant treatment with GLP-1RA in patients with T1D as an opportunity to improve glycemic control, achieve weight loss, and decrease total daily insulin (TDI) requirements in these patients

Bostan E, Akdogan N, Gokoz O

doi: 10.1152/ajpregu.00323.2007

Brand-name medications (e.g., Ozempic, Wegovy) must be purchased through insurance and cannot be paid out-of-pocket through Mochi

Authorities are monitoring how these drugs are being used across different care settings, including telehealth platforms and direct-to-consumer models